McKesson Corporation (MCK) Return on Assets (ROA): 5.78%
Is McKesson Corporation’s return on assets (ROA) high or low?
McKesson Corporation's return on assets (ROA) of 5.78% is 130% above its 5-year average of 2.52%, near the high end of its 5-year range (-6.98%–5.78%).
As of Friday, June 19, 2026. 13.67% above its 12-month average of 5.08%.
MCK Return on Assets (ROA) Chart
MCK Average Return on Assets (ROA) Chart
MCK Current vs Average Return on Assets (ROA) Chart
MCK Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
5.78%
RETURN ON ASSETS (ROA) AVG TTM
5.08%
RETURN ON ASSETS (ROA) AVG 3Y
5.08%
RETURN ON ASSETS (ROA) AVG 5Y
2.52%
RETURN ON ASSETS (ROA) AVG 10Y
2.66%
RETURN ON ASSETS (ROA) AVG 15Y
3.19%
RETURN ON ASSETS (ROA) AVG 20Y
3.37%
CURRENT VS TTM AVG
+13.67%
CURRENT VS 3Y AVG
+13.72%
CURRENT VS 5Y AVG
+129.52%
CURRENT VS 10Y AVG
+117.44%
CURRENT VS 15Y AVG
+81.23%
CURRENT VS 20Y AVG
+71.73%
MCK Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $87.88B | 5.78% | 5.08% | 5.08% | 2.52% |
| Elevance Health Inc. (ELV)vs › | $84.37B | 4.17% | 4.89% | 5.25% | 5.41% |
| HCA Healthcare, Inc. (HCA)vs › | $83.23B | 11.06% | 10.43% | 10.23% | 10.42% |
| Medtronic plc (MDT)vs › | $101.86B | 5.16% | 5.13% | 4.62% | 4.65% |
| Cigna Corporation (CI)vs › | $73.88B | 4.10% | 2.99% | 3.50% | 3.82% |
| Boston Scientific Corporation (BSX)vs › | $67.35B | 8.01% | 5.66% | 4.50% | 3.49% |
| Bristol-Myers Squibb Company (BMY)vs › | $110.27B | 8.41% | -0.92% | 3.28% | 1.99% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $62.84B | 10.82% | 11.40% | 12.40% | 16.97% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $114.63B | 16.38% | 6.37% | 11.74% | 14.58% |
| Stryker Corporation (SYK)vs › | $119.03B | 7.21% | 6.88% | 7.02% | 6.41% |
Asset Efficiency
ROA
5.8%
ROE
-219.2%
McKesson Corporation Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
McKesson Corporation Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for McKesson Corporation (MCK)?
- The return on assets (ROA) for MCK stock is 5.78%.
- Is McKesson Corporation's return on assets (ROA) high or low?
- McKesson Corporation's return on assets (ROA) of 5.78% is 130% above its 5-year average of 2.52%, near the high end of its 5-year range (-6.98%–5.78%).
- What is the TTM average return on assets (ROA) for McKesson Corporation (MCK)?
- The TTM average return on assets (ROA) for MCK stock is 5.08%.
- What is the 3Y average return on assets (ROA) for McKesson Corporation (MCK)?
- The 3Y average return on assets (ROA) for MCK stock is 5.08%.
- What is the 5Y average return on assets (ROA) for McKesson Corporation (MCK)?
- The 5Y average return on assets (ROA) for MCK stock is 2.52%.
- What is the 10Y average return on assets (ROA) for McKesson Corporation (MCK)?
- The 10Y average return on assets (ROA) for MCK stock is 2.66%.
- What is the 15Y average return on assets (ROA) for McKesson Corporation (MCK)?
- The 15Y average return on assets (ROA) for MCK stock is 3.19%.
- What is the 20Y average return on assets (ROA) for McKesson Corporation (MCK)?
- The 20Y average return on assets (ROA) for MCK stock is 3.37%.
McKesson Corporation Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 5.78% |
| 2025-03-31 | 4.39% |
| 2024-03-31 | 4.45% |
| 2023-03-31 | 5.71% |
| 2022-03-31 | 1.76% |
| 2021-03-31 | -6.98% |
| 2020-03-31 | 1.47% |
| 2019-03-31 | 0.06% |
| 2018-03-31 | 0.11% |
| 2017-03-31 | 8.50% |
| 2016-03-31 | 3.99% |
| 2015-03-31 | 2.74% |
| 2014-03-31 | 2.44% |
| 2013-03-31 | 3.85% |
| 2012-03-31 | 4.24% |
| 2011-03-31 | 3.66% |
| 2010-03-31 | 4.48% |
| 2009-03-31 | 3.26% |
| 2008-03-31 | 4.02% |
| 2007-03-31 | 4.02% |
| 2006-03-31 | 3.52% |
| 2005-03-31 | -0.84% |
| 2004-03-31 | 3.98% |
| 2003-03-31 | 3.87% |
| 2002-03-31 | 3.14% |
| 2001-03-31 | -0.42% |
| 2000-03-31 | 6.98% |
| 1999-03-31 | 0.93% |
| 1998-03-31 | 2.76% |
| 1997-03-31 | 2.59% |
Related Metrics
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler